Bénéfices
| Q1 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 0.720 | ||
| Révision: | $558.31M | $573.08M | — |
| Q4 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 0.300 | 0.360 | 0.0600 |
| Révision: | $502.27M | $520.04M | -$12.86M |
| Q3 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 0.850 | 0.680 | -0.1700 |
| Révision: | $555.73M | $634.44M | -$29.32M |
| Q2 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.220 | 1.240 | 0.0200 |
| Révision: | $636.41M | $709.18M | -$67.14M |
